1. Home
  2. ANNX vs CLMB Comparison

ANNX vs CLMB Comparison

Compare ANNX & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.03

Market Cap

726.1M

Sector

Health Care

ML Signal

HOLD

Logo Climb Global Solutions Inc.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$31.80

Market Cap

620.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
CLMB
Founded
2011
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
726.1M
620.7M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ANNX
CLMB
Price
$4.03
$31.80
Analyst Decision
Buy
Strong Buy
Analyst Count
10
3
Target Price
$15.43
★ $32.33
AVG Volume (30 Days)
★ 3.0M
147.6K
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
★ 0.13%
EPS Growth
N/A
★ 14.29
EPS
N/A
★ 0.48
Revenue
N/A
★ $652,517,000.00
Revenue This Year
N/A
$12.32
Revenue Next Year
N/A
$9.32
P/E Ratio
★ N/A
$66.31
Revenue Growth
N/A
★ 40.14
52 Week Low
$2.54
$15.25
52 Week High
$7.18
$79.12

Technical Indicators

Market Signals
Indicator
ANNX
CLMB
Relative Strength Index (RSI) 44.50 55.81
Support Level $3.71 $28.65
Resistance Level $4.37 $32.46
Average True Range (ATR) 0.23 1.12
MACD -0.01 -0.22
Stochastic Oscillator 49.27 37.29

Price Performance

Historical Comparison
ANNX
CLMB

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: